Delta 9 Announces the Establishment of an At-the-Market Equity Offering Program

Published: December 8, 2022

Delta 9 Announces the Establishment of an At-the-Market Equity Offering Program

DELTA 9 CANNABIS INC. announced that it has established an at-the-market equity program (the “ATM Program”) that allows the Company to issue up to $5,000,000 of common shares in the capital of the Company (the “Common Shares”) from treasury to the public from time to time, at the Company’s discretion. Distributions of the Common Shares through the ATM Program will be made pursuant to the terms of an equity distribution agreement (the “Equity Distribution Agreement”) dated December 6, 2022 between the Company and Haywood Securities Inc. (the “Agent”).

Pursuant to the Equity Distribution Agreement, the Common Shares may be offered and sold by the Agent: (a) in privately negotiated transactions with the consent of the Company and, if required, by the Toronto Stock Exchange (the “TSX”); (b) as block transactions; (c) by the Agent, on the TSX or on any other “marketplace” (as such term is defined in National Instrument 21-101 – Marketplace Operation) in Canada; or (d) by any method permitted by law that constitutes an “at-the-market distribution” under National Instrument 44-102 – Shelf Distributions.

The volume and timing of distributions under the ATM Program, if any, will be determined in the Company’s sole discretion. The ATM Program will be effective until the earlier of the issuance and sale of all of the Common Shares issuable pursuant to the ATM Program and October 9, 2023, unless terminated prior to such date by the Company or the Agent. As Common Shares sold in the ATM Program will be issued and sold at the prevailing market price at the time of the sale, prices may vary among purchasers during the period of the distribution. The Company expects to use the net proceeds from the ATM Program for general corporate purposes and working capital needs.

The offering under the ATM Program will be made pursuant to a prospectus supplement dated December 6, 2022 (the “Prospectus Supplement”) to the Company’s final amended and restated short form base shelf prospectus dated November 25, 2022 for the provinces of Canada, except Québec, and the Company’s final base shelf prospectus dated November 25, 2022 for Québec and the territories of Canada (the “Base Shelf Prospectus”).

About Delta 9 Cannabis Inc.
Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses. Delta 9’s wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9’s shares trade on the Toronto Stock Exchange under the symbol “DN” and on the OTCQX under the symbol “DLTNF”. For more information, please visit

Recent News

View All News Items

Latest Article

Marrying Up Cannabis Regulations & Business Opportunities

Marrying Up Cannabis Regulations & Business Opportunities

The evolving Canadian cannabis market provides many opportunities for a variety of products and services that support the cultivation, processing and distribution of cannabis-related items. What’s more, the legal market has fostered a suitable environment for attracting the talents and expertise of legacy market employees and devotees, thus increasing the market’s ‘potency’.

Read Article